IPO registrations (S-1, F-1) · Registrants
OSR Health, Inc.
- SEC CIK
- 1840425 · filings on EDGAR ↗
- Name on the registration
- OSR Holdings, Inc.
- Former names
- OSR Holdings, Inc. (2023–2026); Bellevue Life Sciences Acquisition Corp. (2021–2025)
- Registration
- Form S-1, first filed 2022-04-29, last 2025-06-10; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2023-02-13; declared effective 2023-02-09
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 10900 NE 4TH STREET, SUITE 2300, Bellevue, WA 98004
- EIN
- 84-5052822
- Ticker
- OSRH, OSRHW (OTC, OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- OSR Health, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2023-02-13, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $60,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BLAC
- Lead underwriters
- Chardan
- Syndicate
- J.P. Morgan; Units Chardan Capital Markets LLC (5,950,000); B. Riley Securities (50,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Bellevue Life Sciences Acquisition Corp. EXACT (CIK (EXACT))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-04-29 | S-1 | S-1 (registration) | Bellevue Life Sciences Acquisition Corp. | 0001193125-22-134355 ↗ |
| 2022-05-10 | S-1/A | S-1/A (amendment) | Bellevue Life Sciences Acquisition Corp. | 0001193125-22-145580 ↗ |
| 2022-05-13 | S-1/A | S-1/A (amendment) | Bellevue Life Sciences Acquisition Corp. | 0001193125-22-150293 ↗ |
| 2022-10-07 | S-1/A | S-1/A (amendment) | Bellevue Life Sciences Acquisition Corp. | 0001193125-22-259711 ↗ |
| 2022-11-04 | S-1/A | S-1/A (amendment) | Bellevue Life Sciences Acquisition Corp. | 0001193125-22-277968 ↗ |
| 2023-01-20 | S-1/A | S-1/A (amendment) | Bellevue Life Sciences Acquisition Corp. | 0001193125-23-012151 ↗ |
| 2023-02-09 | EFFECT | EFFECT (declared effective) | Bellevue Life Sciences Acquisition Corp. | 9999999995-23-000346 ↗ |
| 2023-02-13 | 424B4 | 424B4 (final prospectus) | Bellevue Life Sciences Acquisition Corp. | 0001193125-23-035877 ↗ |
| 2025-01-31 | EFFECT | EFFECT (declared effective) | Bellevue Life Sciences Acquisition Corp. | 9999999995-25-000263 ↗ |
| 2025-05-28 | S-1 | S-1 (registration) | OSR Holdings, Inc. | 0001213900-25-048346 ↗ |
| 2025-06-10 | S-1/A | S-1/A (amendment) | OSR Holdings, Inc. | 0001213900-25-053114 ↗ |
| 2025-06-17 | EFFECT | EFFECT (declared effective) | OSR Holdings, Inc. | 9999999995-25-001948 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-20 | S-1/A | registration statement | $10.00 | 6,000,000 | $60,000,000 | Nasdaq BLAC | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ | |
| 2023-02-13 | 424B4 | final prospectus | $10.00 | 6,000,000 | $60,000,000 | Nasdaq BLAC | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bellevue Global Life Science Investors LLC | TenPercentOwner | 5 | 2023–2025 | ||
| Chung In Chul | Director; Other | 2 | 2023 | ||
| Euh Hosun | Director; Other | 2 | 2023 | ||
| Hwang Kuk Hyoun | Director,Officer,TenPercentOwner | Chief Executive Officer; President and CEO; See Remarks | 5 | 2023–2025 | |
| Park Jin Whan | Director; Other | 2 | 2023 | ||
| REED STEVEN | Director; Other | 2 | 2023 | ||
| Roberts Rad | Director; Other | 2 | 2023 | ||
| Whang Jun Chul | Director | 1 | 2023 | ||
| Yoo David Jin | Officer | Chief Financial Officer | 2 | 2023 | |
| Lee Phil Geon | Director | 1 | 2024 | ||
| Kim Sang Hyun | Director | 1 | 2024 | ||
| BCM Europe AG | TenPercentOwner | 1 | 2025 | ||
| Bellevue Capital Management LLC | TenPercentOwner | 1 | 2025 | ||
| Bang Gihyoun | Officer | Chief Financial Officer | 1 | 2025 | |
| Jee Hyuk Joo | Director | 1 | 2025 | ||
| Barberis Alcide | Director | 1 | 2025 | ||
| Cho Joong Myung | Director | 1 | 2025 | ||
| Kim Sang Harry | Officer | See Remarks | 1 | 2025 | |
| Fierz Reto Kaspar | Director | 1 | 2025 | ||
| Kim Yeiseok | Officer | Chief Operating Officer | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | OSR Holdings, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, WA first:
- SONOSITE INC WA
- QUINTON CARDIOLOGY SYSTEMS INC WA
- EMULATE THERAPEUTICS, INC. WA
- VIVOS INC WA
- Avalon Holding Group, Inc. WA
- KESTRA MEDICAL TECHNOLOGIES, LTD. WA
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
In other datasets, the same topic (Technology) in WA:
- Form D issuer: 2nd Watch, Inc. (Form D private offerings)
- Lobbying client: 4G AMERICAS (F/K/A 3G AMERICAS LLC) (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology